Epistaxis and atorvastatin: is there an association and are clinicians aware? A retrospective audit of 100 patients.
CONCLUSION: There was no apparent difference in the proportion of patients admitted with epistaxis taking atorvastatin versus simvastatin. Epistaxis is an unknown side effect of atorvastatin; doctors have an obligation to be aware of the pharmaceutical literature and to consider alternatives, particularly in re-admissions cases.
PMID: 31964433 [PubMed - as supplied by publisher]
Source: Journal of Laryngology and Otology - Category: ENT & OMF Tags: J Laryngol Otol Source Type: research
More News: Atorvastatin Calcium | ENT & OMF | Epistaxis (Nosebleeds) | Lipitor | Simvastatin | Statin Therapy | Study | UK Health | Zivast | Zocor